Drugmaker Valeant pulls forecasts as Pearson returns
Chief executive back at the helm after two-month absence through illness but Robert Ingram retains chairman’s post
Valeant raises forecasts after topping expectations in first quarter
Fast-growing company loses CFO Howard Schiller as it looks to address issues with $11bn Salix Pharma acquisition
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Six Nations 2025
Get the latest news, analysis and match reports from the M6N and W6N championships
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices